Drug Discovery Services Market Size, Scope, and Share by 2030
Drug Discovery Services Market: Strategic Insights
Drug Discovery Services Market
-
CAGR (2022 - 2030)14.3% -
Market Size 2022
US$ 19,539.00 Million -
Market Size 2030
US$ 56,783.29 Million
Market Dynamics
GROWTH DRIVERS
- Increase in research and development activities
- Rising demand for personalized medicines
FUTURE TRENDS
- Increasing adoption of contract research organizations (CROs)
- Integration with AI and machine learning
OPPORTUNITIES
- Expansion in pharmaceutical R&D
- Growth in clinical trial outsourcing
Key Players
- Agilent Technologies Ubiquigent
- Abbott Laboratories Inc
- Advinus Therapeutics Albany Molecular Research Inc
- Aurigene
- Bayer AG
- AstraZeneca PLC
- Charles River Laboratories International
- Covance
- ChemBridge Corporation
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Process
- Target Selection and Validation
- Hit to Lead Identification
Type
- Biology Services
- Medicinal Chemistry
- Drug Metabolism and Pharmacokinetics
Molecule Type
- Biologics and Small Molecules
Therapeutic Area
- Cardiovascular Diseases
- Oncology
- Neurology
- Diabetes
- Respiratory Diseases